Overview

ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy

Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To demonstrate the superiority of ASP8825 over placebo and dose response in patients with painful diabetic polyneuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc